Bristol-Myers Squibb
BMY
#173
Rank
$128.40 B
Marketcap
$62.86
Share price
-1.60%
Change (1 day)
42.38%
Change (1 year)

Operating Margin for Bristol-Myers Squibb (BMY)

Operating Margin as of September 2026 (TTM): 24.21%

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is 24.21%. At the end of 2025 the company had an Operating Margin of 19.35%.

Operating Margin history for Bristol-Myers Squibb from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
202519.35%-211.57%
2024-17.35%-192.51%
202318.75%12.23%
202216.71%-4.29%
202117.46%-208.03%
2020-16.16%-184.93%
201919.03%-28.07%
201826.45%7.11%
201724.70%-18.89%
201630.45%142.76%
201512.54%-16.36%
201414.99%-15.02%
201317.64%32.87%
201213.28%-59.59%
201132.86%5.46%
201031.16%4.61%
200929.79%10.48%
200826.96%47.6%
200718.27%31.33%
200613.91%-39.88%
200523.13%1.48%
200422.80%-9.14%
200325.09%64.53%
200215.25%23.66%
200112.33%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 42.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
27.37% 13.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01%-50.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
13.51%-44.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
42.17% 74.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
27.00% 11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.21%-45.44%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
10.08%-58.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40% 33.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
21.11%-12.80%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.